SARS-CoV-2 (2019-nCoV) Nucleic Acid Detection Kit (RNA Capture Probe Method)

A diagnostic test kit for the detection of SARS-CoV-2 (2019-nCoV) nucleic acids using fluorescence PCR methodology. The kit is designed for COVID-19 diagnostic testing.

A nucleic acid detection kit for the identification of SARS-CoV-2 (2019-nCoV) using fluorescent PCR methodology. It enables rapid diagnosis of COVID-19 infections.

A nucleic acid detection kit for identifying SARS-CoV-2 virus using fluorescent PCR methodology. The kit is designed for rapid COVID-19 diagnosis in clinical and screening applications.

A molecular diagnostics reagent kit for the detection of SARS-CoV-2 (2019-nCoV) nucleic acids using fluorescent PCR methodology. The kit enables rapid diagnosis of COVID-19 infections.

SARS-CoV-2 Nucleic Acid Detection Kit using fluorescent PCR method for rapid and accurate identification of COVID-19 infection. The kit enables qualitative detection of viral RNA in respiratory specimens, supporting clinical diagnosis and epidemiological surveillance. Designed for laboratory use with high sensitivity and specificity.

Rapid antigen detection kit for SARS-CoV-2 using colloidal gold immunochromatography. Delivers qualitative results for COVID-19 diagnosis in clinical and point-of-care settings. Designed for swift patient screening and laboratory confirmation protocols.

An in vitro qualitative diagnostic test kit for detecting COVID-19 antigen N protein in human nasal, nasopharyngeal, and oropharyngeal samples using colloidal gold solid-phase immunochromatography. The kit uses a double antibody sandwich immunoassay principle with a test cassette, swabs, extraction tube, and buffer solution. Results are interpreted within 15 minutes by observing colored bands at control and test lines on the cassette. The kit is intended as a supplementary or auxiliary diagnostic indicator and requires confirmation of positive results; negative results do not exclude infection possibility.

Molecular diagnostic kit specifically designed for detecting novel influenza A H1N1 (2009) virus nucleic acids. Provides auxiliary diagnosis of H1N1 infection in clinical specimens.

A real-time reverse transcription PCR method cartridge for detecting SARS-2-CoV (COVID-19) nucleic acid with 3-plex detection including internal control.

A diagnostic test kit for detecting IgG antibodies against SARS-CoV-2 using magnetic microparticle chemiluminescence method.

This detection cartridge uses real-time reverse transcription PCR method for COVID-19 nucleic acid detection. COVID-19 is an acute respiratory infectious disease caused by novel coronaviruses belonging to the β genus, to which people are generally susceptible. The main source of infection is patients infected by the novel coronavirus; asymptomatic infected people can also be infectious sources. The incubation period is typically 1 to 14 days, mostly 3 to 7 days. Main manifestations include fever, fatigue, and dry cough, with nasal congestion, runny nose, sore throat, myalgia, and diarrhea occurring in some cases.

A real-time reverse transcription PCR method cartridge for detecting SARS-CoV-2 (COVID-19) nucleic acid. The cartridge provides 3-plex detection including an internal control to avoid false negative results and is compatible with the Galaxy Nano system.